Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes

Repaglinide, an oral hypoglycemic agent, is a short-acting insulin secretagogue. We describe a case, in which an extremely low dose of repaglinide caused severe hypoglycemia and novel drug interactions are suggested. A 71-year-old man with type 2 diabetes was taken to the hospital due to consciousne...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetol Int
Auteurs principaux: Komatsu, Hitomi, Enomoto, Mariko, Shiraishi, Hisashi, Morita, Yasuyo, Hashimoto, Daisuke, Nakayama, Shuichi, Funakoshi, Shogo, Hirano, Seiki, Terada, Yoshio, Miyamura, Mitsuhiko, Fujimoto, Shimpei
Format: Artigo
Langue:Inglês
Publié: Springer Singapore 2020
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7538475/
https://ncbi.nlm.nih.gov/pubmed/33088647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-020-00434-w
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires